BIAS
REGN icon

Beacon Investment Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Beacon Investment Advisory Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$472K Sell
757
-9,055
-92% -$6.16M 0.02% 189
2026
Q1 		$7.58M Sell
9,812
-263
-3% -$201K 0.31% 78
2025
Q4 		$7.78M Sell
10,075
-1,450
-13% -$985K 0.32% 73
2025
Q3 		$6.48M Sell
11,525
-11,990
-51% -$6.78M 0.27% 85
2025
Q2 		$12.3M Sell
23,515
-2,744
-10% -$1.53M 0.54% 52
2025
Q1 		$16.7M Buy
26,259
+1,751
+7% +$1.2M 0.78% 45
2024
Q4 		$17.5M Sell
24,508
-2,678
-10% -$2.25M 0.76% 49
2024
Q3 		$28.6M Buy
27,186
+198
+0.7% +$220K 1.19% 28
2024
Q2 		$28.4M Buy
26,988
+592
+2% +$574K 1.22% 27
2024
Q1 		$25.4M Buy
26,396
+407
+2% +$387K 1.1% 30
2023
Q4 		$22.8M Buy
25,989
+7,523
+41% +$6.2M 1.04% 31
2023
Q3 		$15.2M Buy
18,466
+9,225
+100% +$7.25M 0.75% 44
2023
Q2 		$6.64M Buy
9,241
+566
+7% +$436K 0.31% 75
2023
Q1 		$7.13M Buy
8,675
+54
+0.6% +$40.7K 0.35% 67
2022
Q4 		$6.22M Buy
+8,621
New +$6.36M 0.32% 71
2020
Q3 		– Sell
-325
Closed -$203K – 263
2020
Q2 		$203K Buy
+325
New +$184K 0.01% 233
2019
Q2 		– Sell
-519
Closed -$213K – 235
2019
Q1 		$213K Buy
+519
New +$214K 0.02% 215
2018
Q4 		– Sell
-844
Closed -$341K – 262
2018
Q3 		$341K Sell
844
-6
-0.7% -$2.28K 0.03% 206
2018
Q2 		$293K Buy
850
+3
+0.4% +$938 0.03% 215
2018
Q1 		$292K Buy
847
+30
+4% +$10.4K 0.03% 220
2017
Q4 		$307K Sell
817
-167
-17% -$67.6K 0.03% 201
2017
Q3 		$440K Buy
+984
New +$468K 0.04% 190

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Beacon Investment Advisory Services's REGN Position: Q2 2026 in Review

Beacon Investment Advisory Services reduced its Regeneron Pharmaceuticals (REGN) stake by 92% in Q2 2026, selling an estimated $6.16M and leaving 757 shares worth $472K. The position accounts for 0.02% of the portfolio, ranked #189.

Beacon Investment Advisory Services first reported a position in REGN in Q3 2017 and has held it in 22 quarters since. The position peaked at $28.6M in Q3 2024. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Beacon Investment Advisory Services held 757 shares of Regeneron Pharmaceuticals worth $472K as of Q2 2026.
  • Beacon Investment Advisory Services sold 9,055 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $6.16M.
  • Regeneron Pharmaceuticals made up 0.02% of Beacon Investment Advisory Services's portfolio in Q2 2026, its #189 holding.
  • Beacon Investment Advisory Services first reported a position in Regeneron Pharmaceuticals in Q3 2017 and has held it in 22 quarters since.
  • Beacon Investment Advisory Services's Regeneron Pharmaceuticals position peaked at $28.6M in Q3 2024.
  • 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Beacon Investment Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.